The Role of Immunohistochemistry Markers in Endometrial Cancer with Mismatch Repair Deficiency: A Systematic Review.
diagnosis
endometrial cancer
immunohistochemistry markers
microsatellite instability
mismatch repair-deficient
prognosis
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
03 Aug 2022
03 Aug 2022
Historique:
received:
05
06
2022
revised:
28
07
2022
accepted:
29
07
2022
entrez:
12
8
2022
pubmed:
13
8
2022
medline:
13
8
2022
Statut:
epublish
Résumé
The objective of this systematic review was to summarize our current knowledge of the role of immunohistochemistry (IHC) markers for identifying mismatch repair-deficient (MMRd) tumors in endometrial cancer (EC). Identification of MMRd tumors, which occur in 13% to 30% of all ECs, has become critical for patients with colorectal and endometrial cancer for therapeutic management, clinical decision making, and prognosis. This review was conducted by two authors applying the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines using the following terms: "immunohistochemistry and microsatellite instability endometrial cancer" or "immunohistochemistry and mismatch repair endometrial cancer" or "immunohistochemistry and mismatch repair deficient endometrial cancer". Among 596 retrieved studies, 161 fulfilled the inclusion criteria. Articles were classified and presented according to their interest for the diagnosis, prognosis, and theragnostics for patients with MMRd EC. We identified 10, 18, and 96 articles using IHC expression of two, three, or four proteins of the MMR system (MLH1, MSH2, MHS6, and PMS2), respectively. MLH1 promoter methylation was analyzed in 57 articles. Thirty-four articles classified MMRd tumors with IHC markers according to their prognosis in terms of recurrence-free survival (RFS), overall survival (OS), stage, grade, and lymph node invasion. Theragnostics were studied in eight articles underlying the important concentration of PD-L1 in MMRd EC. Even though the role of IHC has been challenged, it represents the most common, robust, and cheapest method for diagnosing MMRd tumors in EC and is a valuable tool for exploring novel biotherapies and treatment modalities.
Identifiants
pubmed: 35954447
pii: cancers14153783
doi: 10.3390/cancers14153783
pmc: PMC9367287
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Int J Gynecol Pathol. 2017 Mar;36(2):128-139
pubmed: 27167671
Am J Surg Pathol. 2014 Jun;38(6):793-800
pubmed: 24503759
Am J Surg Pathol. 2015 Oct;39(10):1370-6
pubmed: 26099011
Gynecol Oncol. 2002 Jul;86(1):62-8
pubmed: 12079302
Int J Gynecol Pathol. 2017 Mar;36(2):115-127
pubmed: 27556954
Gynecol Oncol. 2021 Mar;160(3):771-776
pubmed: 33419609
J Pathol Transl Med. 2021 May;55(3):202-211
pubmed: 33845554
Histopathology. 2020 Jan;76(1):52-63
pubmed: 31846532
Hum Pathol. 2017 Sep;67:69-77
pubmed: 28712776
Genet Med. 2019 Oct;21(10):2167-2180
pubmed: 31086306
Am J Surg Pathol. 2014 Nov;38(11):1501-9
pubmed: 25229768
Cancer. 2001 Jun 1;91(11):2056-64
pubmed: 11391585
Eur J Cancer. 2016 Sep;64:149-58
pubmed: 27420608
Ann Diagn Pathol. 2020 Aug;47:151558
pubmed: 32619922
Hum Mol Genet. 1999 Apr;8(4):661-6
pubmed: 10072435
Hum Pathol. 2019 Oct;92:10-17
pubmed: 31269413
Mod Pathol. 2010 May;23(5):694-702
pubmed: 20173732
Mod Pathol. 2013 Nov;26(11):1514-24
pubmed: 23743934
J Clin Oncol. 2005 Dec 20;23(36):9344-50
pubmed: 16361634
Int J Cancer. 2001 Jan 1;91(1):22-6
pubmed: 11149415
Int J Gynecol Cancer. 2020 May;30(5):640-647
pubmed: 32169874
Adv Anat Pathol. 2017 Nov;24(6):372-378
pubmed: 28820751
Gynecol Oncol. 2013 Jul;130(1):121-6
pubmed: 23612316
J Clin Oncol. 2015 Dec 20;33(36):4301-8
pubmed: 26552419
J Clin Oncol. 2014 Jan 10;32(2):90-100
pubmed: 24323032
Int J Gynecol Cancer. 2015 Mar;25(3):440-6
pubmed: 25695547
Cancer. 2017 Mar 1;123(5):802-813
pubmed: 28061006
Int J Surg Pathol. 2020 Feb;28(1):31-37
pubmed: 31311367
Gynecol Oncol. 2016 Dec;143(3):453-459
pubmed: 27789085
Am J Surg Pathol. 2020 Feb;44(2):263-270
pubmed: 31567195
Am J Surg Pathol. 2015 Aug;39(8):1114-20
pubmed: 25871621
Mod Pathol. 2019 Feb;32(2):252-257
pubmed: 30206407
Arch Pathol Lab Med. 2019 Oct;143(10):1225-1233
pubmed: 30917047
Medicine (Baltimore). 2018 Oct;97(43):e12968
pubmed: 30412119
Obstet Gynecol. 2008 May;111(5):1161-6
pubmed: 18448750
J Pathol Transl Med. 2020 Nov;54(6):471-479
pubmed: 32867011
Pathol Oncol Res. 2020 Jul;26(3):1417-1427
pubmed: 32377987
Mod Pathol. 2001 Aug;14(8):777-83
pubmed: 11504837
Fam Cancer. 2009;8(4):501-4
pubmed: 19672700
J Clin Pathol. 2021 Jan;74(1):36-42
pubmed: 32513848
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Lancet Oncol. 2020 Oct;21(10):1353-1365
pubmed: 32919526
Tumour Biol. 2017 Sep;39(9):1010428317725834
pubmed: 28946809
Gynecol Oncol. 2017 Jun;145(3):446-452
pubmed: 28347512
Am J Surg Pathol. 2016 May;40(5):577-86
pubmed: 26945341
Ulster Med J. 2008 Jan;77(1):25-30
pubmed: 18269114
Int J Gynecol Pathol. 2015 Sep;34(5):403-10
pubmed: 26262451
Eur J Obstet Gynecol Reprod Biol. 2021 Jan;256:478-483
pubmed: 33189427
J Natl Compr Canc Netw. 2019 Aug 1;17(8):896-909
pubmed: 31390583
CA Cancer J Clin. 2022 Jan;72(1):7-33
pubmed: 35020204
Am J Clin Pathol. 2005 Jul;124(1):89-96
pubmed: 15923161
Am J Surg Pathol. 2016 Feb;40(2):166-180
pubmed: 26492180
PLoS One. 2018 Apr 19;13(4):e0195572
pubmed: 29672549
Am J Surg Pathol. 2007 Jun;31(6):846-53
pubmed: 17527071
Hum Pathol. 2005 Jun;36(6):605-19
pubmed: 16021566
Cancer Biol Med. 2020 May 15;17(2):458-467
pubmed: 32587781
Histopathology. 2015 Oct;67(4):474-82
pubmed: 25648330
Nature. 1994 Mar 17;368(6468):258-61
pubmed: 8145827
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Virchows Arch. 2001 Jan;438(1):39-48
pubmed: 11213834
Gynecol Oncol. 2020 Oct;159(1):229-238
pubmed: 32694065
Int J Cancer. 2008 Mar 1;122(5):1077-81
pubmed: 17973265
Mod Pathol. 2014 Feb;27(2):255-61
pubmed: 23887303
J Exp Clin Cancer Res. 2008 Dec 31;27:88
pubmed: 19116039
Gynecol Oncol. 2019 Sep;154(3):467-474
pubmed: 31248668
Mod Pathol. 2015 Jun;28(6):836-44
pubmed: 25720322
Gynecol Oncol. 2012 May;125(2):414-20
pubmed: 22306203
Curr Opin Genet Dev. 1995 Jun;5(3):382-95
pubmed: 7549435
Am J Surg Pathol. 2017 Mar;41(3):326-333
pubmed: 27984238
Int J Gynecol Pathol. 2020 Nov;39(6):537-545
pubmed: 32281774
Acta Histochem. 2020 Apr;122(3):151505
pubmed: 31955910
Am J Surg Pathol. 2012 Dec;36(12):1771-81
pubmed: 23154767
Int J Gynecol Cancer. 2018 Oct;28(8):1624-1630
pubmed: 30095707
Am J Surg Pathol. 2012 May;36(5):753-61
pubmed: 22498825
Mod Pathol. 2010 Jun;23(6):781-9
pubmed: 20305618
Gynecol Oncol. 2010 Mar;116(3):516-21
pubmed: 20034658
Cancer. 2018 Aug 1;124(15):3145-3153
pubmed: 29750335
Am J Surg Pathol. 2019 Apr;43(4):531-537
pubmed: 30585826
J Gynecol Oncol. 2019 May;30(3):e46
pubmed: 30887763
J Obstet Gynaecol Res. 2019 Oct;45(10):2037-2042
pubmed: 31307113
J Clin Oncol. 2008 Dec 20;26(36):5965-71
pubmed: 19001318
Am J Surg Pathol. 2019 May;43(5):591-600
pubmed: 30864976
Int J Cancer. 2001 May 1;92(3):398-403
pubmed: 11291077
Clin Cancer Res. 2004 Jan 15;10(2):481-90
pubmed: 14760069
Hum Cell. 2011 Jun;24(2):65-73
pubmed: 21547354
Jpn J Clin Oncol. 2021 Feb 8;51(2):167-172
pubmed: 33244581
J Pathol. 2020 Mar;250(3):336-345
pubmed: 31829441
Int J Cancer. 2000 Apr 1;86(1):60-6
pubmed: 10728595
Gynecol Oncol. 2018 Jun;149(3):570-574
pubmed: 29656794
Ann Oncol. 2017 Jan 1;28(1):96-102
pubmed: 27742654
Int J Gynecol Cancer. 2020 Jul;30(7):993-999
pubmed: 32376735
Int J Clin Exp Pathol. 2014 Sep 15;7(10):7297-303
pubmed: 25400828
PLoS One. 2013 Nov 07;8(11):e79737
pubmed: 24244552
Int J Gynecol Pathol. 2016 Jan;35(1):8-15
pubmed: 25851713
N Engl J Med. 2018 Apr 05;378(14):1277-1290
pubmed: 29562145
Int J Gynecol Pathol. 2004 Jan;23(1):18-25
pubmed: 14668545
Appl Immunohistochem Mol Morphol. 2019 Oct;27(9):678-682
pubmed: 31567138
Arch Gynecol Obstet. 2017 Jul;296(1):123-127
pubmed: 28510097
Gynecol Oncol. 2010 May;117(2):234-8
pubmed: 20153885
Hum Pathol. 2013 Feb;44(2):218-25
pubmed: 22955108
J Obstet Gynaecol Res. 2010 Apr;36(2):336-43
pubmed: 20492385
Am J Surg Pathol. 2009 Dec;33(12):1869-77
pubmed: 19898223
Gynecol Oncol. 2014 May;133(2):340-5
pubmed: 24530564
BJOG. 2017 Sep;124(10):1576-1583
pubmed: 28128512
Cancer. 2019 Feb 1;125(3):398-405
pubmed: 30561762
Histopathology. 2006 Feb;48(3):275-85
pubmed: 16430474
Cancer Res. 1996 Jan 15;56(2):235-40
pubmed: 8542572
Gynecol Oncol. 2020 Feb;156(2):393-399
pubmed: 31882243
Int J Mol Sci. 2019 Jul 31;20(15):
pubmed: 31370215
Pathol Res Pract. 2020 Jan;216(1):152581
pubmed: 31402167
Gynecol Oncol. 2021 Jan;160(1):148-160
pubmed: 33190932
Curr Opin Obstet Gynecol. 2009 Feb;21(1):31-8
pubmed: 19125001
Int J Gynecol Pathol. 2019 Jan;38(1):44-51
pubmed: 29210800
Jpn J Clin Oncol. 2021 Jan 1;51(1):60-69
pubmed: 32844218
PLoS One. 2019 Aug 30;14(8):e0221419
pubmed: 31469860
Int J Oncol. 2009 Nov;35(5):977-82
pubmed: 19787250
Cancer. 2019 Sep 15;125(18):3172-3183
pubmed: 31150123
Pathology. 2015 Aug;47(5):439-45
pubmed: 26126041
N Engl J Med. 2017 Oct 5;377(14):1345-1356
pubmed: 28889792
Gastroenterology. 2008 Aug;135(2):419-28
pubmed: 18602922
Int J Gynecol Pathol. 2014 Nov;33(6):554-9
pubmed: 25272293
Histol Histopathol. 2014 Nov;29(11):1455-66
pubmed: 24811063
Int J Gynecol Cancer. 2021 Jan;31(1):12-39
pubmed: 33397713
Cancer. 2003 Oct 1;98(7):1540-6
pubmed: 14508843
Am J Surg Pathol. 2019 Nov;43(11):1493-1500
pubmed: 31478942
Gynecol Oncol. 2014 Aug;134(2):319-25
pubmed: 24933100
Mod Pathol. 2013 Nov;26(11):1525-35
pubmed: 23702729
Hum Pathol. 2017 Apr;62:33-39
pubmed: 27864117
Mod Pathol. 2003 Nov;16(11):1148-58
pubmed: 14614055
Int J Gynecol Pathol. 2016 Sep;35(5):410-8
pubmed: 26598976
Cancer Control. 2009 Jan;16(1):14-22
pubmed: 19078925
Gynecol Oncol. 2016 Feb;140(2):226-33
pubmed: 26644264
Gynecol Oncol. 2020 Apr;157(1):245-251
pubmed: 31980219
J Obstet Gynaecol Res. 2006 Oct;32(5):454-60
pubmed: 16984511
Gynecol Oncol. 2020 Jul;158(1):3-11
pubmed: 32331700
Am J Surg Pathol. 2016 Feb;40(2):155-65
pubmed: 26523542
Clin Cancer Res. 2016 Jun 15;22(12):2865-73
pubmed: 26763250
Pathology. 2017 Aug;49(5):457-464
pubmed: 28669579
Int J Gynecol Pathol. 2014 Sep;33(5):483-91
pubmed: 25083964
Am J Surg Pathol. 2016 Jul;40(7):909-16
pubmed: 27186853
J Clin Oncol. 2020 Oct 10;38(29):3388-3397
pubmed: 32749941
Curr Pharm Des. 2014;20(11):1655-63
pubmed: 23888949
Bull Cancer. 2019 Feb;106(2):114-118
pubmed: 30409467
Int J Surg Pathol. 2016 Jun;24(4):297-305
pubmed: 26842347
Bull Cancer. 2017 Jan;104(1):42-51
pubmed: 27979364
Am J Surg Pathol. 2016 Jun;40(6):770-6
pubmed: 26848797
Am J Surg Pathol. 2018 May;42(5):561-568
pubmed: 29505428
Nature. 1994 Sep 1;371(6492):75-80
pubmed: 8072530
Am J Surg Pathol. 2021 Mar 1;45(3):421-429
pubmed: 33021522
J Clin Oncol. 2004 Dec 15;22(24):4934-43
pubmed: 15611508
Hum Genet. 2006 Mar;119(1-2):206-11
pubmed: 16408224
Gynecol Oncol. 2011 Oct;123(1):88-94
pubmed: 21742371
Clin Genet. 2005 Dec;68(6):533-41
pubmed: 16283884
Asian Pac J Cancer Prev. 2019 Sep 01;20(9):2601-2606
pubmed: 31554352
Gastroenterology. 1996 Apr;110(4):1020-7
pubmed: 8612988
Gynecol Oncol. 2015 May;137(2):306-10
pubmed: 25636458
Hum Pathol. 2018 Feb;72:100-106
pubmed: 29133142
Fam Cancer. 2010 Jun;9(2):131-9
pubmed: 19821155
Int J Gynecol Cancer. 2004 Sep-Oct;14(5):957-65
pubmed: 15361209
Cell. 1993 Dec 3;75(5):1027-38
pubmed: 8252616
Int J Gynecol Pathol. 2003 Apr;22(2):141-8
pubmed: 12649668
Cancer. 2002 May 1;94(9):2502-10
pubmed: 12015776
Am J Surg Pathol. 2020 Feb;44(2):174-181
pubmed: 31651527
Hum Pathol. 2018 Nov;81:235-244
pubmed: 30420047
Am J Surg Pathol. 2009 Jun;33(6):925-33
pubmed: 19238076
Nature. 2013 May 2;497(7447):67-73
pubmed: 23636398
Mod Pathol. 2006 Oct;19(10):1333-8
pubmed: 16810312
Int J Gynecol Cancer. 2018 Jan;28(1):59-68
pubmed: 29053481
PLoS Med. 2020 Sep 17;17(9):e1003263
pubmed: 32941469
Gynecol Oncol. 2014 Jul;134(1):20-3
pubmed: 24814467
J Natl Compr Canc Netw. 2018 Feb;16(2):170-199
pubmed: 29439178
Sci Rep. 2020 Oct 2;10(1):16386
pubmed: 33009475
Int J Gynecol Pathol. 2019 Nov;38(6):533-542
pubmed: 30383610
J Clin Oncol. 2005 Jul 20;23(21):4609-16
pubmed: 15837969
Mod Pathol. 2019 May;32(5):650-658
pubmed: 30443012
Anticancer Res. 2009 Nov;29(11):4833-7
pubmed: 20032443
Hum Pathol. 2017 Dec;70:121-128
pubmed: 29107668
Gynecol Oncol. 2009 May;113(2):153-8
pubmed: 19275958
Histopathology. 2020 Jan;76(2):336-338
pubmed: 31433862
J Clin Oncol. 2020 Apr 10;38(11):1154-1163
pubmed: 31961766
Mod Pathol. 2019 Oct;32(10):1508-1520
pubmed: 31186530